Dennis McKenna

The company that MAPS formed, Lycos, to bring MDMA to the market had like $50 million involved in this, and they did clinical trials with MDMA for trauma, and it was very effective. But there was an FDA review board. Most of the people on the board were not really clinicians. None of them had any experience themselves with any of these psychedelics or any really clinical trials.

The company that MAPS formed, Lycos, to bring MDMA to the market had like $50 million involved in this, and they did clinical trials with MDMA for trauma, and it was very effective. But there was an FDA review board. Most of the people on the board were not really clinicians. None of them had any experience themselves with any of these psychedelics or any really clinical trials.

And they said, well, It wasn't a well-controlled study because you didn't have the right placebos. You didn't design it correctly. And so we don't accept these results. And as a result, we don't approve MDMA. And the psychiatric community is saying, but wait a minute, this showed profound effectiveness for treating PTSD. You can't just dismiss this.

And they said, well, It wasn't a well-controlled study because you didn't have the right placebos. You didn't design it correctly. And so we don't accept these results. And as a result, we don't approve MDMA. And the psychiatric community is saying, but wait a minute, this showed profound effectiveness for treating PTSD. You can't just dismiss this.

And they said, well, It wasn't a well-controlled study because you didn't have the right placebos. You didn't design it correctly. And so we don't accept these results. And as a result, we don't approve MDMA. And the psychiatric community is saying, but wait a minute, this showed profound effectiveness for treating PTSD. You can't just dismiss this.

And the FDA is saying, well, actually, we can dismiss it. And we hold the keys. And you guys didn't meet the criteria for design of the study that we insist on because it wasn't a placebo-controlled study. And so nobody knows where that's going. I mean, they said basically design a better study or a different study. But I mean, it's created a big problem.

And the FDA is saying, well, actually, we can dismiss it. And we hold the keys. And you guys didn't meet the criteria for design of the study that we insist on because it wasn't a placebo-controlled study. And so nobody knows where that's going. I mean, they said basically design a better study or a different study. But I mean, it's created a big problem.

And the FDA is saying, well, actually, we can dismiss it. And we hold the keys. And you guys didn't meet the criteria for design of the study that we insist on because it wasn't a placebo-controlled study. And so nobody knows where that's going. I mean, they said basically design a better study or a different study. But I mean, it's created a big problem.

And I don't know where it's going to go in terms of the advancement of psychedelic therapies in biomedicine. But, you know, I mean, it may be that psychedelics will not go anywhere because of this, because of this insistence, because the whole... pharmaceutical-industrial complex is so rigid in the way that they regard this. So we'll see. Anyway, to bring it back to coca again, what I wanted to...

And I don't know where it's going to go in terms of the advancement of psychedelic therapies in biomedicine. But, you know, I mean, it may be that psychedelics will not go anywhere because of this, because of this insistence, because the whole... pharmaceutical-industrial complex is so rigid in the way that they regard this. So we'll see. Anyway, to bring it back to coca again, what I wanted to...

And I don't know where it's going to go in terms of the advancement of psychedelic therapies in biomedicine. But, you know, I mean, it may be that psychedelics will not go anywhere because of this, because of this insistence, because the whole... pharmaceutical-industrial complex is so rigid in the way that they regard this. So we'll see. Anyway, to bring it back to coca again, what I wanted to...

The point I want to make when I deliver my talk is that coca is a good example of, you know, cocaine was isolated from coca. And it's one of these pure compounds that has many of the properties but not all of the properties of coca. But that's been the fixation. And it's caused so much damage, you know, on the – geopolitically, socially, everything else.

The point I want to make when I deliver my talk is that coca is a good example of, you know, cocaine was isolated from coca. And it's one of these pure compounds that has many of the properties but not all of the properties of coca. But that's been the fixation. And it's caused so much damage, you know, on the – geopolitically, socially, everything else.

The point I want to make when I deliver my talk is that coca is a good example of, you know, cocaine was isolated from coca. And it's one of these pure compounds that has many of the properties but not all of the properties of coca. But that's been the fixation. And it's caused so much damage, you know, on the – geopolitically, socially, everything else.

I mean, not only is it a toxic, harmful drug, but the political impact it's had has been tremendous. Tremendously negative. The drug cartels who control the production and distribution of cocaine, basically these indigenous families or families of farmers that...

I mean, not only is it a toxic, harmful drug, but the political impact it's had has been tremendous. Tremendously negative. The drug cartels who control the production and distribution of cocaine, basically these indigenous families or families of farmers that...

I mean, not only is it a toxic, harmful drug, but the political impact it's had has been tremendous. Tremendously negative. The drug cartels who control the production and distribution of cocaine, basically these indigenous families or families of farmers that...

cultivate coca they just go and they just say well you know you're working for us now you know they don't want to work for them but they just say we're working you're working for us and if you don't work for us we'll kill you you know and then they deal kill a few of them to keep to set an example and then the whole cartel thing controls the production of cocaine if cocaine were legalized

cultivate coca they just go and they just say well you know you're working for us now you know they don't want to work for them but they just say we're working you're working for us and if you don't work for us we'll kill you you know and then they deal kill a few of them to keep to set an example and then the whole cartel thing controls the production of cocaine if cocaine were legalized

cultivate coca they just go and they just say well you know you're working for us now you know they don't want to work for them but they just say we're working you're working for us and if you don't work for us we'll kill you you know and then they deal kill a few of them to keep to set an example and then the whole cartel thing controls the production of cocaine if cocaine were legalized